On October 31st, the company Medtronic received US Federal Food and Drug Administration approval to treat Narrow Iliac arteries with the use of the Cobalt Chromium Balloon Expendable Stent.
A day later, the company Abbottt received an FDA approval for the Drug Eluting Stent XIENCE PRIME.
This may seem like coincidental timing, but Medtronic and Abbottt have long been rivals in the medical industry. Stents, in particular, led to a lawsuit in 2009 which forced Medtronic...
↧
